TG Therapeutics (TGTX) Announces Receipt of FDA Orphan Drug Designation for TG-1101 as NMO, NMOSD Treatment
Tweet Send to a Friend
TG Therapeutics, Inc. (NASDAQ: TGTX) announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
